Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
Anticoagulation medication and vitrectomy
Sirolimus gains FDA approval
Development of vision analysis system
Evisceration linked to explosion injuries
 

Survey

Would you use anticoagulation medication during diabetic pars plana vitrectomy?

Click here to vote

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.

Click here to contact Neil Hanley, sales manager.

November 23, 2011
Anticoagulants and antiplatelets are safe to use during pars plana vitrectomy
Continuing the use of anticoagulants and antiplatelets during diabetic pars plana vitrectomy does not pose a higher risk of intraoperative or postoperative vitreous haemorrhage. More...
Orphan drug designation for uveitis treatment approved
Santen announced the FDA approval of the orphan drug designation of sirolimus, a uveitis treatment. More...
Collaboration to develop and market vision analysis system
Visiometrics and Medeuronet have formed together to develop and market Visiometrics' Optical Quality Analysis System (OQAS). More...
Evisceration and enucleation strongly linked to ocular injuries from IEDs
Ocular injuries caused by improvised explosive devices (IEDs) are strongly associated with severe ocular damage repaired by evisceration or enucleation. More...
Survey
At Ophthalmology Times Europe we would like to know more about the choices our readers make on behalf of their Dry Eye patients.
By clicking here and completing our short survey you could have a chance to win one of three iPad2’s!

Closing date for completed surveys is 9th December 2011 . Click here...

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH. United Kingdom